| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 657,930 | 603,256 | 536,011 | 610,729 | | Cost of Revenue | (46,846) | (33,267) | 37,146 | 42,967 | | | Gross Profit | 704,776 | 636,523 | 498,865 | 567,762 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 403,942 | 348,493 | 209,730 | 224,522 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 38,173 | 8,428 | 46,119 | 27,041 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 222,591 | 279,602 | 243,016 | 316,199 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (2,003) |
-
|
-
| | Earnings Before Interest And Taxes | 237,756 | 277,599 | 243,016 | 316,199 | | Interest Expense | (17,081) | (2,147) | 18,756 | 15,637 | | Income Before Tax | 254,837 | 279,746 | 224,260 | 300,562 | | Income Tax Expense | 98,097 | 109,209 | 92,230 | 116,164 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 156,740 | 170,537 | 132,030 | 184,398 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 156,740 | 170,537 | 132,030 | 184,398 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $156,740 | $170,537 | $132,030 | $184,398 |
|
0.20% Nasdaq 
Income Statement
